21 – 40 of 155
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
Seeding of protein aggregation causes cognitive impairment in rat model of cortical synucleinopathy
(
- Contribution to journal › Article
- 2018
-
Mark
mGlu receptors in the treatment of Parkinson's disease and L-DOPA-induced dyskinesia
(
- Contribution to journal › Scientific review
-
Mark
Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats
(
- Contribution to journal › Article
-
Mark
On the neuronal circuitry mediating l-DOPA-induced dyskinesia
(
- Contribution to journal › Article
-
Mark
Animal models of l-dopa-induced dyskinesia in Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy : translational implications for interventional therapies
(
- Contribution to journal › Article
- 2017
-
Mark
CK2 oppositely modulates L-DOPA-induced dyskinesia via striatal projection neurons expressing D1 or D2 receptors
(
- Contribution to journal › Article
-
Mark
Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia
(
- Contribution to journal › Article
-
Mark
Translating scientific advances into disease-modifying therapies for Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Molecular Mechanisms of L-DOPA-Induced Dyskinesia
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Differential effects of gaseous versus injectable anesthetics on changes in regional cerebral blood flow and metabolism induced by l-DOPA in a rat model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy
(
- Contribution to journal › Article
-
Mark
Etiology and pathogenesis of parkinson’s disease
2017) p.95-101(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2016
-
Mark
Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice.
(
- Contribution to journal › Article
-
Mark
On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats.
(
- Contribution to journal › Letter
-
Mark
Oral and infusion levodopa therapy in the management of Parkinson’s disease
2016) p.63-75(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Signaling mechanisms in L-DOPA-induced dyskinesia
2016) p.155-188(
- Chapter in Book/Report/Conference proceeding › Book chapter